Logo-jnp
J Nephropathol. 2020;9(1): e05. doi: 10.15171/jnp.2020.05

Review

Intravenous contrast agents in diabetic patients taking metformin; an updated review on current concepts

Masoumeh Asgharpour 1 ORCID, Rouzbeh Danialy 2 ORCID, Seyedhadi Mirhashemi 3 * ORCID, Semko Ebrahimi 5 ORCID

Cited by CrossRef: 2

1- Maleki A, Hayes A, Karimi G. Exploiting the cardioprotective potential of metformin against cardiotoxic agents. Naunyn-Schmiedeberg's Arch Pharmacol. 2025;398(12):16293 [Crossref]
2- Vasiliev D, Kardashova M, Levshina A, Drapkina O. Contrast-induced nephropathy in endovascular surgery: current strategies and new potential. Cardiovasc Ther Prev. 2026;25(8):4795 [Crossref]